# Wegovy Tablet Launches in the UK: Everything You Need to Know
The UK has become one of the first countries in the world to approve an oral semaglutide tablet specifically for weight management. On 11 June 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisation for Wegovy tablets — the same active ingredient as the injectable Wegovy pen, now in a once-daily pill form. For the millions of people who were reluctant to self-inject, this is a significant moment.
This article covers what the approval means, which providers are already accepting pre-orders, what prices look like right now, and what you should realistically expect over the coming months.
> Wegovy tablets are a prescription-only medicine. Always consult a qualified healthcare professional before starting or changing treatment.
—
## What exactly has been approved?
The MHRA has approved oral semaglutide tablets — branded Wegovy — for weight management in adults with a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. This mirrors the eligibility criteria applied to the injectable form.
The approved dosing schedule starts at 1.5mg daily and escalates slowly over several months: 1.5mg → 4mg → 9mg → 25mg. This gradual approach is deliberate — it allows the body to adjust and reduces the severity of gastrointestinal side effects that can occur at higher doses.
The approval is based on strong clinical evidence, including the OASIS 2 trial, which showed an average body weight reduction of 15.1% over 68 weeks at the highest dose. Half of trial participants lost 15% or more of their body weight.
—
## Which providers are taking pre-orders right now?
Seven UK online pharmacies and private prescribing services opened pre-orders within days of the MHRA approval. All are GPhC-registered and offering free delivery. Pre-orders are binding commitments to supply when stock arrives — expected for most providers in July 2026.
Here is a summary of current pre-order prices for the starting dose (1.5mg, one month’s supply):
| Provider | Monthly Price | Delivery |
|—|—|—|
| Bolt Pharmacy | £64.00 | Free |
| Juniper | £79.00 | Free |
| Oxford Online Pharmacy | £82.95 | Free |
| Chemist 4 U | £84.99 | Free |
| Medino | £89.99 | Free |
| Manual | £94.00 | Free |
| Pharmacy2U | £113.95 | Free |
Prices are for the starting dose tier only. As the dose escalates, monthly costs will rise — a factor that is easy to overlook when making your initial decision. Our [12-month cost calculator](/oral-wegovy-12-month-cost/) shows the realistic total cost across the full dose escalation schedule.
—
## Why are prices so different between providers?
The variation in price — nearly £50 between the cheapest and most expensive provider — reflects different commercial models rather than differences in the medicine itself. The tablet is the same formulation regardless of which GPhC-registered provider you use. Differences come down to:
– **Service model** — some providers include ongoing clinical monitoring, app access, or regular check-ins at a higher price point; others offer a streamlined prescription service
– **Consultation fees** — some providers charge separately for the initial clinical assessment; others include it in the monthly price
– **Business positioning** — some providers are targeting premium positioning; others are competing on price to acquire customers early in the market
Our [Price Truth Engine](/providers/) calculates the true first-month cost for every provider, accounting for any consultation fees, delivery charges, and available discount codes.
—
## Is Wegovy tablet on the NHS?
Not yet, and not imminently. The MHRA approval grants a licence for the medicine to be used in the UK — but it does not require or automatically trigger NHS funding. NHS availability requires a separate recommendation from the National Institute for Health and Care Excellence (NICE), which evaluates cost-effectiveness.
As of June 2026, NICE has not begun an evaluation of oral Wegovy for weight management. The injectable form of Wegovy is available on the NHS, but only through highly restricted specialist pathways (typically for people with a BMI of 40 or above, through specialist weight management services with limited capacity). Private prescription remains the only realistic route for most people who want to start treatment promptly.
—
## What happens next?
The commercial launch — meaning physical stock available for dispatch — is expected in July 2026 for most tier-1 providers. Pre-orders placed now will be fulfilled in dispatch order, so joining early may mean a shorter wait.
Beyond that, the UK oral GLP-1 landscape is likely to become more competitive over the next 12–18 months. Orforglipron, Eli Lilly’s once-daily oral GLP-1 tablet (which does not require fasting), is currently in Phase 3 trials and could seek UK regulatory approval as early as 2027. Greater choice typically means downward pressure on prices.
In the meantime, if you are considering oral Wegovy, the most useful steps are: compare verified provider prices, check whether you meet the eligibility criteria (BMI 30+, or 27+ with a qualifying health condition), and speak with a healthcare professional about whether oral semaglutide is appropriate for your situation.
—
## Compare pre-order prices now
CompareWegovyPrices.co.uk tracks all 80 UK providers — from those already taking pre-orders to those still preparing to launch. Our comparison table is updated regularly with verified prices, delivery information, and discount codes.
[Compare all Wegovy tablet prices →](/providers/)
You can also [sign up for a price alert](/providers/) to be notified when prices change or when new providers launch. With prices ranging from £64 to £113.95 for the same starting-dose tablet, it pays to compare before you commit.
—
*This article is for informational purposes only and does not constitute medical advice. Wegovy tablets (semaglutide) are a prescription-only medicine in the UK. Always consult a registered healthcare professional before starting any weight management treatment. Prices correct as of 20 June 2026 — verify directly with providers before purchasing. CompareWegovyPrices.co.uk is not affiliated with Novo Nordisk.*
